---
title: "Cardiovascular drug research after high-profile trial failures and safety alarms"
id: "stat-news-6-the-future-of-heart-drug-research-in-the-wake-of-study-setbacks"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-6-the-future-of-heart-drug-research-in-the-wake-of-study-setbacks"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/?utm_campaign=rss"
published_at: "2026-11-13T13:34:45.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cardiovascular drug research after high-profile trial failures and safety alarms
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-6-the-future-of-heart-drug-research-in-the-wake-of-study-setbacks
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/?utm_campaign=rss)
- **Published At:** 2026-11-13T13:34:45.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Two late-stage clinical trial readouts presented at this year’s American Heart Association meeting showed no benefit for two heart-disease drugs that had been considered genetically validated. The podcast hosts reported these negative results dominated conversation at the meeting. - The Readout LOUD episode convened senior medical writer Matthew Herper with hosts Adam Feuerstein and Elaine Chen to interpret how those trial failures could affect the direction of **cardiovascular disease** drug discovery and investment. - The discussion linked the trial disappointments to broader questions about the predictive value of human genetics for drug targets; investigators observed that genetic validation did not guarantee clinical benefit in these cases. - The podcast also reviewed safety concerns affecting major companies: the hosts noted ongoing drug-safety issues weighing on **Vertex Pharmaceuticals** and **Novartis**, though the source did not provide specific safety-event details. - Market signals were mentioned: **Alnylam** experienced a notable stock decline driven by investor concerns about future growth, as the episode reported. - The episode emphasized uncertainty about what the negative trials mean for future cardiovascular R&D priorities, and it raised open questions about how sponsors, regulators, and investors will respond. - The source did not report trial names, dosing regimens, sample sizes, endpoints, p-values, or other methodological particulars; those specifics remain unreported in the piece. - The podcast encouraged listeners to follow The Readout LOUD for ongoing coverage, and it positioned this edition as a practical conversation rather than a detailed clinical trial report.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [research](https://www.statnews.com/topic/research/) [RFK Jr.](https://www.statnews.com/topic/rfk-jr/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [The Readout LOUD](https://www.statnews.com/category/readout-loud/) # The future of heart drug research in the wake of study setbacks * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2024/07/ROL_Rectangle-645x645.jpg) ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) Nov. 13, 2026 ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") adam.feuerstein@statnews.com Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") 2. [](https://x.com/elaineywchen "X") elaine.chen@statnews.com Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts On this week’s episode of “The Readout LOUD”: the failure of two closely followed heart disease drugs and how these setbacks may impact the future of cardiovascular drug research. Plus, drug safety concerns weigh on some of the biggest companies in the sector. For years, it was widely believed that a deeper understanding of genetics was going to speed the development of newer and better medicines for patients with heart disease. But then came this year’s American Heart Association meeting, which was dominated by presentations of clinical trials that showed no benefit whatsoever for two drugs long thought to be genetically validated. Advertisement Joining us to help sort out this cardiovascular conundrum and what it might portend for the future of drug research is our colleague and senior medical writer Matthew Herper. We also chat about drug safety concerns weighing on Vertex Pharmaceuticals and Novartis, and Alnylam’s stock price tumbling on growth concerns. Be sure to sign up for “The Readout LOUD” on [Apple Podcasts](https://podcasts.apple.com/us/podcast/the-readout-loud/id1354473987), [Spotify](https://open.spotify.com/show/7c181EiST5DhX4Zh2kt7Tq), or wherever you get your podcasts. Advertisement [biotechnology](https://www.statnews.com/topic/biotechnology/), [cardiovascular disease](https://www.statnews.com/topic/cardiovascular-disease/), [Novartis](https://www.statnews.com/topic/novartis/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [Vertex](https://www.statnews.com/topic/vertex/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") 2. Senior Writer, Biotech 1. [](https://x.com/adamfeuerstein "X") 2. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. 2. ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") National Biotech Reporter 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1544077528-80x80.jpeg) [American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/11/GettyImages-2304299477-80x80.jpg) [Senator-elect Abdul El-Sayed on restoring trust in science, the state of public health, and RFK Jr.](https://www.statnews.com/2026/11/13/senator-abdul-el-sayed-interview-public-health-rfk-jr-trust-in-science/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/05/AP26023803702193-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say](https://www.statnews.com/2026/11/13/oura-acquisition-counsel-health-eli-lilly/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/11/2026-Basal-Ganglia-Package-Photos-9-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scientists debut map of basal ganglia, a key brain region involved in an array of diseases](https://www.statnews.com/2026/11/12/brain-map-basal-ganglia-offers-treatment-clues-parkinsons-schizophrenia/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/11/DisConnect_021-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Across the U.S., homegrown experiments aim to save kids from their phones](https://www.statnews.com/2026/11/13/phone-addiction-young-people-fight-back-attention-activism/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/10/STATatHLTH_Wordpress_CalendarImage-80x80.jpg) STAT@hlth. A Dose of Reality on EHRs and AI In-person Nov 18 ](https://www.statnews.com/event/stathlth-a-dose-of-reality-on-ehrs-and-ai/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/BTE2027_Wordpress_CalendarImage-80x80.jpg) 2027 Breakthrough Summit East New York City, NY Mar 18 ](https://www.statnews.com/event/2027-stat-breakthrough-summit-east/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_6400491-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA warns GLP-1 drugs carry potential risk of rare eye condition](https://www.statnews.com/2026/11/09/glp-1-drugs-potential-risk-rare-eye-condition-naion-fda/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391451620_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug](https://www.statnews.com/pharmalot/2026/11/10/former-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug/) 3. ![](https://www.statnews.com/wp-content/uploads/2019/09/AP_060324030695-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves novel Bayer drug to reduce recurrence of stroke](https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1874804219-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Beyond statins, one drug lowered heart attack risk by 20%](https://www.statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/11/F0367611-Adeno-associated_virus_illustration-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [New tumor cases show common gene therapy tool can come with risk](https://www.statnews.com/2026/11/06/novartis-zolgensma-gene-therapy-tumor-risk/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD November 6, 2026 ### [ Democrats’ midterm victory, and a questionable fertility procedure ](https://www.statnews.com/2026/11/06/readout-loud-podcast-midterm-elections-fertility-ivf-mrt-therapy/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) and [Damian Garde](https://www.statnews.com/staff/damian-garde/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD October 30, 2026 ### [ Assessing Merck and Moderna’s mRNA cancer vaccine ](https://www.statnews.com/2026/10/30/readout-loud-podcast-oncology-cancer-vaccine-moderna-merck-amgen-roche/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/), [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), and [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD October 23, 2026 ### [ Remembering STAT’s Helen Branswell ](https://www.statnews.com/2026/10/23/readout-loud-podcast-remembering-helen-branswell-infectious-disease/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/), [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), and [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD October 16, 2026 ### [ Hospitals’ next lucrative bet — longevity clinics ](https://www.statnews.com/2026/10/16/readout-loud-podcast-hospitals-longevity-clinics-northwestern/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/), [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), and [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD October 8, 2026 ### [ NIH funding uncertainty thwarts U.S. researchers ](https://www.statnews.com/2026/10/08/readout-loud-podcast-nih-funding-research-biotech-caribou-nobel-prize/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/), [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/), and [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT
## Related Clinical Research

- [Watchman cardiac implant: clinicians raise questions as Boston Scientific intensifies sales push](https://medichelpline.com/clinical-feed/stat-news-1-stat-doctors-have-questions-about-the-watchman-boston-scientific-has-a-sales.md)
- [Stopping Statins at Age 75 in Low‑Risk Adults: French Trial Found No Increase in Deaths](https://medichelpline.com/clinical-feed/stat-news-0-stopping-statins-in-people-over-75-at-low-risk-for-heart-disease-didn-t.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.